Besides regulating p53, ECT2 deficiency leads to the sustained activation of poly (ADP-ribose) polymerase 1 and facilitates the repair of ribosomal DNA damage, promoting radiotherapy resistance in lung and nasopharyngeal carcinoma cells [51]. This evidence concerns the gene ECT2 and nasopharyngeal carcinoma.